Should we use the oral selective IP receptor agonist selexipag off-label in children with pulmonary arterial hypertension?
| Title: | Should we use the oral selective IP receptor agonist selexipag off-label in children with pulmonary arterial hypertension? |
|---|---|
| Authors: | Martin Koestenberger, Georg Hansmann |
| Source: | Pulmonary Circulation, Vol 8 (2018) |
| Publisher Information: | Wiley, 2018. |
| Publication Year: | 2018 |
| Collection: | LCC:Diseases of the circulatory (Cardiovascular) system LCC:Diseases of the respiratory system |
| Subject Terms: | Diseases of the circulatory (Cardiovascular) system, RC666-701, Diseases of the respiratory system, RC705-779 |
| More Details: | We discuss the currently available data on the use of the prostacyclin mimetic selexipag in children and adolescents with pulmonary arterial hypertension (PAH). Future indications may include transitioning from intravenous prostacyclin/prostacyclin analog to oral selexipag, and vice versa, or adding selexipag as a third oral PAH-targeted agent in children not responding well to dual PAH therapy. |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 2045-8940 20458940 |
| Relation: | https://doaj.org/toc/2045-8940 |
| DOI: | 10.1177/2045894018793580 |
| Access URL: | https://doaj.org/article/5586e0aa9be64f0a84e85940ad031ae1 |
| Accession Number: | edsdoj.5586e0aa9be64f0a84e85940ad031ae1 |
| Database: | Directory of Open Access Journals |
| ISSN: | 20458940 |
|---|---|
| DOI: | 10.1177/2045894018793580 |
| Published in: | Pulmonary Circulation |
| Language: | English |